8DGT image
Entry Detail
PDB ID:
8DGT
EMDB ID:
Keywords:
Title:
Cryo-EM structure of a RAS/RAF complex (state 2)
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2022-06-24
Release Date:
2023-07-05
Method Details:
Experimental Method:
Resolution:
3.90 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Serine/threonine-protein kinase B-raf
Chain IDs:A
Chain Length:805
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Dual specificity mitogen-activated protein kinase kinase 1
Chain IDs:B
Chain Length:414
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:14-3-3 protein zeta
Chain IDs:C, D
Chain Length:247
Number of Molecules:2
Biological Source:Spodoptera exigua
Polymer Type:polypeptide(L)
Description:GTPase KRas isoform X2
Chain IDs:E (auth: F)
Chain Length:191
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP A SER modified residue
Primary Citation
Cryo-EM structure of a RAS/RAF recruitment complex.
Nat Commun 14 4580 4580 (2023)
PMID: 37516774 DOI: 10.1038/s41467-023-40299-6

Abstact

RAF-family kinases are activated by recruitment to the plasma membrane by GTP-bound RAS, whereupon they initiate signaling through the MAP kinase cascade. Prior structural studies of KRAS with RAF have focused on the isolated RAS-binding and cysteine-rich domains of RAF (RBD and CRD, respectively), which interact directly with RAS. Here we describe cryo-EM structures of a KRAS bound to intact BRAF in an autoinhibited state with MEK1 and a 14-3-3 dimer. Analysis of this KRAS/BRAF/MEK1/14-3-3 complex reveals KRAS bound to the RAS-binding domain of BRAF, captured in two orientations. Core autoinhibitory interactions in the complex are unperturbed by binding of KRAS and in vitro activation studies confirm that KRAS binding is insufficient to activate BRAF, absent membrane recruitment. These structures illustrate the separability of binding and activation of BRAF by RAS and suggest stabilization of this pre-activation intermediate as an alternative therapeutic strategy to blocking binding of KRAS.

Legend

Protein

Chemical

Disease

Primary Citation of related structures